Pemicu 4 Saraf - Venia
Pemicu 4 Saraf - Venia
Pemicu 4 Saraf - Venia
Homunculus
Epidural hematom
Subarachnoid Hemorrhage
• Biasanya akibat ruptur aneurisma A. serebral, AVM
• Manifestasi klinis :
– Nyeri kepala mendadak yang sangat parah,
penurunan kesadaran, muntah, kekakuan leher
• Diagnosis :
– TD naik, suhu > 39oC selama 2 minggu pertama,
rangsang meningeal +, preretinal globular
subhyaloid hemorrhage
– CT scan, pungsi lumbal (CSF ada darah), supernatan
dari sentrifugasi CSF xanthochromic, EKG
Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. 8th Ed. McGraw-Hill; 2012.
• Treatment :
– Bed rest with the head elevated 15-20o
– Mild sedation
– Analgesic
– Normal saline if hypotension
– Nimodipine 60 mg PO q4h for 21 days
– Surgical
• Aneurysm clipping the neck of aneurysm or
endovascular placement of a coil to induce clotting
• AVM en-bloc resection or obliterated by ligation
of feeding vessels or by embolization with a local
intra-arterial catheter
Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. 8th Ed. McGraw-Hill; 2012.
• Komplikasi :
– Recurrence of hemorrhage
– Intraparenchymal extension of hemorrhage
– Arterial vasospasm
– Acute or subacute hydrocephalus
– Seizure
• DD :
– Bakterial meningitis
– Traumatic lumbal puncture
Greenberg DA, Aminoff MJ, Simon RP. Clinical Neurology. 8th Ed. McGraw-Hill; 2012.
DEMENSIA, ALZHEIMER, PARKINSON
• Dementia with Lewy Bodies progressive
and degenerative dementia of unknown
etiology motor signs (visual hallucinations
and episodes of reduced responsiveness)
http://emedicine.medscape.com/article/1135041-clinical
• Patients with DLB usually have imapired
cognition consistent with dementia (MMSE)
• DLB laboratory studies :
– Chemistry panel
– CBC
– Vitamin B-12 levels
http://emedicine.medscape.com/article/1135041-workup
• CSF findings in DLB include the following :
– Patients with Alzheimer disease have higher levels
of tau protein in their CSF than do patients with DLB
– Patients with LB variant of Alzheimer disease (LBV-
AD) have intermediate values
– CSF levels of beta amyloid are lower than normal in
DLB, Alzheimer disease, and LBV-AD; however, CSF
beta-amyloid levels in DLB, LBV-AD, and Alzheimer
disease do not differ from each other
http://emedicine.medscape.com/article/1135041-workup
• Brain imaging : MRI
• Lewy body composite risk factors
http://emedicine.medscape.com/article/1135041-treatment
• Treatment :
– Acetylcholinesterase inhibitors
– Antipsychotics 2nd generation
– Antidepressants
– Benzodiazepines
– Dopamine precursors
http://emedicine.medscape.com/article/1135041-treatment
• Alzheimer disease is an acquired disorder of
cognitive and behavioral impairment that
markedly interferes with social and
occupational functioning incurable disease
with a long and progressive course
http://emedicine.medscape.com/article/1134817-overview
• Signs and symptoms : • Problems recognizing
friends and family
– Mild : members
• Memory loss • Difficulty organizing
• Confusion thought and thinking
• Increased anxiety logicalliy
– Moderate : – Severe :
• Shortened attention • Weight loss
span • Seizures, skin
infections, difficulty
swallowing
• Lack of bladder and
bowel control
http://emedicine.medscape.com/article/1134817-overview
• Initial mental status testing should include
evaluation of the following:
– Attention and concentration
– Recent and remote memory
– Language
– Praxis (ie, ability to perform skilled motor tasks
without nonverbal prompting)
– Executive function
– Visuospatial function
http://emedicine.medscape.com/article/1134817-clinical#b3
• AD can be classified into the following stages:
– Preclinical
– Mild
– Moderate
– Severe
http://emedicine.medscape.com/article/1134817-clinical#b4
• Diagnosis :
– CT scan
– MRI
– Blood studies
– EEG
– Lumbar puncture
http://emedicine.medscape.com/article/1134817-workup#c13
• Treatment :
– Acetylcholine / glutamate
– Antidepressants
– Anxiolytics
– Antiparkinsonian agents
– Beta-blockers
– Antiepileptic drugs (for their effects on behavior)
– Neuroleptics
http://emedicine.medscape.com/article/1134817-treatment
• Parkinson disease is one of the most common
neurologic disorders and causing progressive
disability that can be slowed but not halted by
treatment
• 2 Major neuropathologic findings :
– Loss of pigmented dopaminergic neurons of the
substansia nigra pars compacta
– The presence of lewy bodies and lewy neurites
http://emedicine.medscape.com/article/1831191-overview
• Signs and symptoms :
– Tremor
– Decreased facial expression
– Sleep disturbances
– Decreased sense of smell
– Depression or anhedonia
– Slowness in thinking
http://emedicine.medscape.com/article/1831191-overview
• Non motor symptoms are common in early
parkinson disease
http://emedicine.medscape.com/article/1831191-overview
• Diagnosis :
– 2 from3 cardinal signs :
• Resting tremor
• Rigidity
• Bradykinesia
http://emedicine.medscape.com/article/1831191-overview
• Brain imaging : MRI
• Lumbar puncture
http://emedicine.medscape.com/article/1831191-overview
• Management :
– Symptomatic drug therapy
– Treatment for nonmotor symptoms
http://emedicine.medscape.com/article/1831191-overview
T.I.A
ETIOLOGI
FAKTOR RESIKO • Bekuan darah pada arteri di otak
• Bekuan darah dari bagian tubuh
• Merokok lain (mis: jantung) yang menuju ke
• Hipertensi otak
• Hiperkolesterol • Trauma pada pembuluh darah
• Diabetes • Konstriksi pembuluh darah yang
• Gangguan hematologi menuju ke otak
• Gangguan hematologi
polisitemia, sickle cell anemia,
trombositosis, leukemia
• Keadaan yang menyebabkan
abnormalitas pembuluh darah
fibromuscular dysplasia, SLE
• Inflamasi pembuluh darah
arteritis, poliarteritis
• Spasme pembuluh darah kecil di
otak
T.I.A
GEJALA
• TIA terjadi secara tiba-tiba dan
biasanya berlangsung selama Gejala lain :
2-30 menit, jarang > 1-2 jam. • Hilangnya rasa atau kelainan
• mengenai arteri karotis : sensasi pada lengan atau
kebutaan pada salah satu mata tungkai atau salah satu sisi
atau kelainan rasa dan tubuh
kelemahan • Kelemahan atau kelumpuhan
• A. Vertebralis : pusing, pada lengan atau tungkai
penglihatan ganda dan atau salah satu sisi tubuh
kelemahan menyeluruh • Hilangnya sebagian
penglihatan atau
pendengaran
• Penglihatan ganda